Spyre Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Spyre Therapeutics stock have an average target of 50, with a low estimate of 40 and a high estimate of 65. The average target predicts an increase of 295.26% from the current stock price of 12.65.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$40	$50	$45	$65
Change	+216.21%	+295.26%	+255.73%	+413.83%

Analyst Ratings

The average analyst rating for Spyre Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	4	3	3	3	3	2
Buy	5	4	4	4	4	5
Hold	0	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Faisal Khurshid Leerink Partners	Leerink Partners	Buy Initiates $45	Buy	Initiates	$45	+255.73%	Apr 8, 2025
Debanjana Chatterjee Jones Trading	Jones Trading	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Dec 11, 2024
Colleen Kusy Baird	Baird	Buy Maintains $50 → $65	Buy	Maintains	$50 → $65	+413.83%	Nov 13, 2024
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Maintains $50 → $65	Strong Buy	Maintains	$50 → $65	+413.83%	Oct 25, 2024
David Nierengarten Wedbush	Wedbush	Buy Initiates $45	Buy	Initiates	$45	+255.73%	Sep 4, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.52

from -3.18

EPS Next Year

-3.61

from -3.52

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	18.74M	2.33M	886.00K	-	-	-	-
Revenue Growth	-	-	-87.57%	-61.96%	-	-	-	-
EPS	-37.89	-25.02	-24.86	-13.76	-3.18	-3.52	-3.61	-3.86
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	12	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.83	-2.08	-1.71
Avg	-3.52	-3.61	-3.86
Low	-4.31	-5.06	-5.81

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.